Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer.

@article{Gray1981ValueOS,
  title={Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer.},
  author={Bruce Nathaniel Gray and Cheryl Ann Hilton Walker and Rochelle Barnard},
  journal={The Medical journal of Australia},
  year={1981},
  volume={1 4},
  pages={
          177-8
        }
}
Carcinoembryonic antigen (CEA) has been monitored at intervals of approximately three months in patients who had undergone potentially curative surgery for breast cancer, head and neck cancer, lung cancer, and colorectal cancer, but who were considered to be at high risk of recurrence. Monitoring of CEA in patients' serum was of no value for the early detection of tumour recurrence in either breast or head and neck cancer patients. It was of value for the early detection of lung cancer… CONTINUE READING